BACKGROUND: Patient-specific and disease-specific factors shape the course of chronic rhinosinusitis (CRS) and its response to treatment, with optimal management involving interventions tailored to these factors. Recent evidence suggests CRS inflammatory signatures depend on age. The objective of this study was to determine whether age also influences quality-of-life (QOL) and postoperative outcomes. METHODS: Retrospective analysis of prospectively collected QOL data from 403 adults with medically refractory CRS who underwent functional endoscopic sinus surgery (FESS) at a tertiary care medical center between 2014 and 2018 was undertaken. Total and subdomain scores from the 22-item Sino-Nasal Outcome Test (SNOT-22) and the Short Form 8 Health Survey (SF-8) measure of general health completed at preoperative and postoperative visits were reviewed. RESULTS: Patients were divided into young (18 to 39 years, n = 100), middle-aged (40 to 59 years, n = 172), and elderly (≥60 years, n = 131) groups. Baseline total SNOT-22 scores differed between groups (p = 0.01), with middle-aged patients having the highest symptom burden and elderly patients having the lowest. Similar patterns were observed for SNOT-22 subdomains. Elderly patients reported smaller improvements and were less likely to achieve a minimally important clinical difference. CRS patients had worse SF-8 scores compared to the general population, and elderly patients were the least likely to match population norms following surgery. Age was an independent predictor of QOL outcomes after FESS. CONCLUSION: Age may play a significant role in CRS pathophysiology, symptom burden, and surgical outcomes. Elderly patients report smaller improvements in disease-specific and general health QOL after surgery. CRS management in the elderly population should incorporate age-dependent differences in symptom burden and expectations into treatment algorithms.
BACKGROUND:Patient-specific and disease-specific factors shape the course of chronic rhinosinusitis (CRS) and its response to treatment, with optimal management involving interventions tailored to these factors. Recent evidence suggests CRS inflammatory signatures depend on age. The objective of this study was to determine whether age also influences quality-of-life (QOL) and postoperative outcomes. METHODS: Retrospective analysis of prospectively collected QOL data from 403 adults with medically refractory CRS who underwent functional endoscopic sinus surgery (FESS) at a tertiary care medical center between 2014 and 2018 was undertaken. Total and subdomain scores from the 22-item Sino-Nasal Outcome Test (SNOT-22) and the Short Form 8 Health Survey (SF-8) measure of general health completed at preoperative and postoperative visits were reviewed. RESULTS:Patients were divided into young (18 to 39 years, n = 100), middle-aged (40 to 59 years, n = 172), and elderly (≥60 years, n = 131) groups. Baseline total SNOT-22 scores differed between groups (p = 0.01), with middle-aged patients having the highest symptom burden and elderly patients having the lowest. Similar patterns were observed for SNOT-22 subdomains. Elderly patients reported smaller improvements and were less likely to achieve a minimally important clinical difference. CRSpatients had worse SF-8 scores compared to the general population, and elderly patients were the least likely to match population norms following surgery. Age was an independent predictor of QOL outcomes after FESS. CONCLUSION:Age may play a significant role in CRS pathophysiology, symptom burden, and surgical outcomes. Elderly patients report smaller improvements in disease-specific and general health QOL after surgery. CRS management in the elderly population should incorporate age-dependent differences in symptom burden and expectations into treatment algorithms.
Authors: Avrom Caplan; Nicole Fett; Misha Rosenbach; Victoria P Werth; Robert G Micheletti Journal: J Am Acad Dermatol Date: 2017-01 Impact factor: 11.527
Authors: Shail M Govani; Wyndy L Wiitala; Ryan W Stidham; Sameer D Saini; Jason K Hou; Linda A Feagins; Jeremy B Sussman; Peter D R Higgins; Akbar K Waljee Journal: Inflamm Bowel Dis Date: 2016-08 Impact factor: 5.325
Authors: Devyani Lal; Kimberly B Golisch; Zachary A Elwell; Rohit D Divekar; Matthew A Rank; Yu-Hui Chang Journal: Int Forum Allergy Rhinol Date: 2016-04-15 Impact factor: 3.858
Authors: Seong H Cho; Seung J Hong; Brian Han; Sun H Lee; Lydia Suh; James Norton; David Lin; David B Conley; Rakesh Chandra; Robert C Kern; Bruce K Tan; Atsushi Kato; Anju Peters; Leslie C Grammer; Robert P Schleimer Journal: J Allergy Clin Immunol Date: 2012-01-10 Impact factor: 10.793
Authors: Chi Sang Hwang; Hye Sun Lee; Si Nae Kim; Ji Hyung Kim; Dong-Joon Park; Kyung-Su Kim Journal: Am J Rhinol Allergy Date: 2018-11-28 Impact factor: 2.467
Authors: Seong H Cho; Dae Woo Kim; Sun H Lee; Narasaiah Kolliputi; Seung J Hong; Lydia Suh; James Norton; Kathryn E Hulse; Sudarshan Seshadri; David B Conley; Robert C Kern; Bruce K Tan; Anju Peters; Leslie C Grammer; Robert P Schleimer Journal: Am J Respir Cell Mol Biol Date: 2015-11 Impact factor: 6.914
Authors: Mitesh P Mehta; Kevin Hur; Caroline P E Price; Stephanie Shintani-Smith; Kevin C Welch; David B Conley; Robert C Kern; Bruce K Tan Journal: Laryngoscope Investig Otolaryngol Date: 2021-09-18